| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/23/2000 | EP1028848A1 Prepolymer compositions comprising an antimicrobial agent |
| 08/23/2000 | EP1028774A1 Biodegradable, anionic polymers derived from the amino acid l-tyrosine |
| 08/23/2000 | EP1028748A1 Compositions providing for increased igf-i solubility |
| 08/23/2000 | EP1028747A1 Novel igf-i composition and its use |
| 08/23/2000 | EP1028746A1 Method for producing igf-i sustained-release formulations |
| 08/23/2000 | EP1028736A1 Bovine teat dip |
| 08/23/2000 | EP1028733A1 Use of mixtures of active agents containing phytostenol for producing hypocholesteraemic preparations |
| 08/23/2000 | EP1028731A2 Stable antiandrogenic gel composition |
| 08/23/2000 | EP1028730A1 Compositions of lipid lowering agents |
| 08/23/2000 | EP1028727A1 Skin penetration enhancing components |
| 08/23/2000 | EP1028724A1 Transdermal delivery of 3,4-diarylchromans |
| 08/23/2000 | EP1028722A1 Pharmaceutically active composition containing artemisinine and/or a derivative of artemisinine |
| 08/23/2000 | EP1028720A1 Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| 08/23/2000 | EP1028719A1 Treatment of attention deficit hyperactivity disorder and narcolepsy |
| 08/23/2000 | EP1028718A2 Extended release formulation containing venlafaxin |
| 08/23/2000 | EP1028715A1 Dosage composition for nasal delivery and method of use of the same |
| 08/23/2000 | EP1028714A1 Vitamin composition |
| 08/23/2000 | EP1028713A1 A process for making a free-flowing, dust-free, cold water dispersible, edible, film-coating composition |
| 08/23/2000 | EP1028712A2 Solid solution beadlet |
| 08/23/2000 | EP1028711A1 Method for producing liposomes |
| 08/23/2000 | EP1028710A1 Topical compositions for nsai drug delivery |
| 08/23/2000 | EP1028709A1 Novel once-a-day controlled release sulfonylurea formulation |
| 08/23/2000 | EP1028708A1 Topical compositions for prostaglandin e 1? delivery |
| 08/23/2000 | EP1028707A1 Sustained release ophthalmic compositions containing water soluble medicaments |
| 08/23/2000 | EP1028706A1 Buffered drug formulations for transdermal electrotransport delivery |
| 08/23/2000 | EP1028682A1 Transdermal propentofylline compositions for the treatment of alzheimer's disease |
| 08/23/2000 | EP0960139A4 Elastomer treatment process to decrease peroxide levels |
| 08/23/2000 | EP0959872A4 Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth |
| 08/23/2000 | EP0726920B1 Process for preparing high molecular weight polyesterpolycarbonates |
| 08/23/2000 | EP0684840B1 Method of preparing colloidal aqueous solutions of active substances which are only slightly soluble in water, and a lipid for use in the method |
| 08/23/2000 | EP0674506B1 Controlled release growth hormone containing microspheres |
| 08/23/2000 | CN1264310A Polymer based pharmaceutical compositions for targeted delivery of biologically active agents |
| 08/23/2000 | CN1264309A Biofunctional polymers prepared in supercritical fluid |
| 08/23/2000 | CN1264306A Method for treatment of diarrhea disease and removing special bacterial population |
| 08/23/2000 | CN1264299A Improved rapidly disintegratable multiparticulate tablet |
| 08/23/2000 | CN1264298A Bright white film coatings and film coating compositions therefor |
| 08/23/2000 | CN1264297A New liposome vectors of active principles |
| 08/23/2000 | CN1264296A Powder compositions of unilamellar liposomes |
| 08/23/2000 | CN1264295A Lipid complexes and liposomes of highly insoluble platinum complexes |
| 08/23/2000 | CN1263771A Black plaster and preparing process thereof |
| 08/23/2000 | CN1263765A Compound oral liquid of cactus |
| 08/23/2000 | CN1055640C Human calcium degrading gene concerned peptide fatty composite and preparation thereof |
| 08/23/2000 | CN1055639C Health-care medicine |
| 08/23/2000 | CN1055634C Emplastrum for lowering blood viscosity |
| 08/23/2000 | CN1055633C Emplastrum for preventing and treating coronary heart disease |
| 08/23/2000 | CN1055630C Notoginseng-red sage tablet and preparation method thereof |
| 08/23/2000 | CN1055629C Making up method for medicinal liquid of ice guide therapeutic method on channels and acupuncture point |
| 08/23/2000 | CN1055626C Orally traditional Chinese medicine for orthopedics disease |
| 08/23/2000 | CN1055624C Scorpion-and-ant oral liquid and its preparation method |
| 08/23/2000 | CN1055621C Medicinal liquid for treating foot sweat (bad smell) |
| 08/23/2000 | CN1055619C Health-care cigarette plaster and preparation method thereof |
| 08/23/2000 | CN1055618C Method for preparing prolonged release microcapsules |
| 08/23/2000 | CN1055617C Oral medicament form |
| 08/22/2000 | US6107397 Free-radical aqueous emulsion polymerization using a water soluble initiator and monomers selected from n-vinyl-lactams (6-8 carbons), n-vinylformamide and n-methyl-n-vinylacetamide and a monounsaturated hydrophobic monomer; coatings, etc |
| 08/22/2000 | US6107347 Bimodal molecular weight hyaluronate formulations and methods for using same |
| 08/22/2000 | US6107344 Sealing teats |
| 08/22/2000 | US6107333 Parenteral paclitaxel in a stable non-toxic formulation |
| 08/22/2000 | US6107332 Anticancer agents; antiinflammatory agents |
| 08/22/2000 | US6107290 Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof |
| 08/22/2000 | US6107289 Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β |
| 08/22/2000 | US6107285 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 08/22/2000 | US6107277 Calcitonin salmon analogues |
| 08/22/2000 | US6107276 Therapeutic mixtures with triglyceride oils or polyoxyethylene glycol, sorbitan derivatives(surfactants) and crosslinked poyvinylpyrrolidone(carrier), for improved solubility and oral administration |
| 08/22/2000 | US6107102 Therapeutic microdevices and methods of making and using same |
| 08/22/2000 | US6106930 Preparation consisting of a surface-adhering, film-like or wafer-like administration form |
| 08/22/2000 | US6106867 Gelatinized propolis food products |
| 08/22/2000 | US6106865 Mixture of microcrystalline cellulose, compressibility, silica and surfactants |
| 08/22/2000 | US6106864 Pharmaceutical formulations containing darifenacin |
| 08/22/2000 | US6106863 Sustained-release metal valproate tablets |
| 08/22/2000 | US6106862 Once daily analgesic tablet |
| 08/22/2000 | US6106861 Tablets that disintegrate in the mouth |
| 08/22/2000 | US6106860 Fatty ester of glycerol, diglycerol up to pentadecaglycerol as carriers for antibiotics |
| 08/22/2000 | US6106859 Stabilization of lipid:DNA formulations during nebulization |
| 08/22/2000 | US6106858 Loading active materials of liposomes by dissolving |
| 08/22/2000 | US6106856 Drug delivery through skin |
| 08/22/2000 | US6106855 Wound healing agents of proteins, oil in water emulsions and applying to skin |
| 08/22/2000 | US6106848 Anionic amphiphilic polymer emulsifier |
| 08/22/2000 | US6106845 Tube with one end configured for fluid flow and the other for suction application; dentistry |
| 08/22/2000 | US6106839 Ayurvedic composition for the treatment of disorders of the nervous system including Parkinson's disease |
| 08/22/2000 | US6106837 Inhalation of green apple odorant |
| 08/22/2000 | US6106836 Container with freeze-dried vaccine components |
| 08/22/2000 | US6106835 Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators |
| 08/22/2000 | US6106819 Administering anesthetic and antiinflammatory agent to eye |
| 08/22/2000 | US6106815 Shampoo composition containing methyl vinyl ether/maleic anhydride decadiene crosspolymer and capsules |
| 08/22/2000 | US6106814 Hair conditioning compositions |
| 08/22/2000 | US6106810 Polyquaternium-37, salt, polyoxyalkylene glycol and polar solvent; atomizable, leave-on hair |
| 08/22/2000 | US6106286 Method and device for administering medicine to the periodontium |
| 08/22/2000 | CA2183882C Pharmaceutical excipient having improved compressibility |
| 08/22/2000 | CA2111002C Non-chlorofluorocarbon aerosol formulations |
| 08/22/2000 | CA2054933C Filter for parenteral systems |
| 08/17/2000 | WO2000047758A2 Methods of making compounds |
| 08/17/2000 | WO2000047741A1 Glycosylated leptin compositions and related methods |
| 08/17/2000 | WO2000047716A2 Fibres for culturing eukaryotic cells |
| 08/17/2000 | WO2000047668A1 Freeze-dried agent containing paramylon, production and utilization thereof |
| 08/17/2000 | WO2000047644A1 A biocompatible adhesive system and a bioadhesive drug delivery system with controllable release |
| 08/17/2000 | WO2000047601A1 Shortened-chain polynucleotides and process for the preparation thereof |
| 08/17/2000 | WO2000047591A1 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents |
| 08/17/2000 | WO2000047581A1 Therapeutic nucleoside compound |
| 08/17/2000 | WO2000047551A2 Inhibitors of aspartyl protease |
| 08/17/2000 | WO2000047237A1 Encapsulated cells containing an amplified expression vector as a drug delivery device |